The inactivation of p53, either through mutations or other mechanisms, may contribute to the progression from well-differentiated thyroid cancer to ATC, suggesting that TP53 alterations could represent a later event in cancer development [20,57]. The gene discussed is TP53; the disease is thyroid gland carcinoma.